Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Daniel Dornbusch
|
| gptkbp:developedBy |
HIV cure therapies
gene editing therapies for viral infections |
| gptkbp:focusesOn |
CRISPR technology
gene editing therapeutics for viral diseases |
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://excision.bio/
|
| gptkbp:bfsParent |
gptkb:Artis_Ventures
gptkb:Prosperity7_Ventures |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Excision BioTherapeutics
|